New hope for lymphoma patients in japan as drug trial advances
NCT ID NCT04533581
First seen Nov 01, 2025 · Last updated May 19, 2026 · Updated 35 times
Summary
This study tests an experimental drug called ME-401 in 61 Japanese adults whose indolent B-cell non-Hodgkin's lymphoma has returned or stopped responding to at least two prior treatments. The goal is to see if the drug can shrink tumors and how safe it is. Participants must not have taken similar targeted drugs before.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for INDOLENT B-CELL NON-HODGKIN'S LYMPHOMA are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
Aichi Cancer Center Hospital
Nagoya, Aichi-ken, Japan
-
Akita University Hospital
Akita, Japan
-
Anjo Kosei Hospital
Anjo, Aichi-ken, Japan
-
Aomori Prefectural Central Hospital
Aomori, Japan
-
Chiba Cancer Center
Chiba, Japan
-
Chugoku Central Hospital
Fukuyama, Hiroshima, Japan
-
Gunma University Hospital
Maebashi, Gunma, Japan
-
Hokkaido University Hospital
Sapporo, Hokkaido, Japan
-
Ishikawa Prefectural Central Hospital
Kanazawa, Ishikawa-ken, Japan
-
Japanese Red Cross Kyoto Daini Hospital
Kyoto, Japan
-
Japanese Red Cross Nagoya Daini Hospital
Nagoya, Aichi-ken, Japan
-
Jichi Medical University Hospital
Shimotsuke, Tochigi, Japan
-
Kagoshima University Hospital
Kagoshima, Japan
-
Kameda Medical Center
Kamogawa, Chiba, Japan
-
Kindai University Hospital
Sayama, Osaka, Japan
-
Kurashiki Central Hospital
Kurashiki, Okayama-ken, Japan
-
Kyushu University Hospital
Fukuoka, Japan
-
Mie University Hospital
Tsu, Mie-ken, Japan
-
National Cancer Center Hospital
Chuo-ku, Tokyo, Japan
-
National Hospital Organization Kumamoto Medical Center
Kumamoto, Japan
-
National Hospital Organization Kyushu Medical Center
Fukuoka, Japan
-
National Hospital Organization Nagoya Medical Center
Nagoya, Aichi-ken, Japan
-
National Hospital Organization Shikoku Cancer Center
Matsuyama, Ehime, Japan
-
Okayama University Hospital
Okayama, Japan
-
Osaka University Hospital
Suita, Osaka, Japan
-
Saitama Medical University International Medical Center
Hidaka, Saitama, Japan
-
The Cancer Institute Hospital Of JFCR
Koto-ku, Tokyo, Japan
-
Tohoku University Hospital
Sendai, Miyagi, Japan
-
Tokyo Metropolitan Komagome Hospital
Bunkyo-ku, Tokyo, Japan
-
Tottori University Hospital
Yonago, Tottori, Japan
Conditions
Explore the condition pages connected to this study.